(Q34366011)

1 August 2017

1 reference

title

New perspectives on the role of aldosterone excess in cardiovascular disease (English)

1 reference

1 August 2017

main subject

cardiovascular disease

1 reference

Stowasser M

1

1 reference

1 August 2017

publication date

1 October 2001

1 reference

Clinical and Experimental Pharmacology and Physiology

1 August 2017

published in

1 reference

1 August 2017

volume

28

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

783-791

1 reference

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Mineralocorticoids, hypertension, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

High affinity aldosterone binding sites (type I receptors) in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Hormonal regulation of cardiac fibroblast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Aldosterone biosynthesis in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Mineralocorticoid modulation of central control of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Aldosterone reduces baroreceptor discharge in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Aldosterone escape during ACE inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

Primary aldosteronism: learning from the study of familial varieties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03523.X

10.1046/J.1440-1681.2001.03523.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference